1-3 of 3
Dag Torfoss
Close
Sort by
Journal Articles

Arterial Thromboembolism in Cancer Patients Treated with Apixaban

Trine-Lise Larsen, Jorunn Brekke, Herish Garresori, Hege Frøen, Eva-Marie Jacobsen, Dag Torfoss, Hilde Skuterud Wik, Tone Ronnaug Enden, Alina Carmen Porojnicu, Petter Quist-Paulsen, Elin Velle, Per Morten Sandset, Anne Hansen Ree, Anders E.A. Dahm
Journal: Blood
Blood (2022) 140 (Supplement 1): 11366–11367.
https://doi.org/10.1182/blood-2022-160363
Published: 2022
Journal Articles

Low Dose Apixaban As Secondary Prophylaxis for Venous Thromboembolism in Cancer Patients, 30 Months Follow-up

Trine-Lise Hannevik, Herish Garresori, Jorunn Brekke, Tone Ronnaug Enden, Hege Froen, Eva-Marie Jacobsen, Petter Quist-Paulsen, Alina Carmen Porojnicu, Anne Hansen Ree, Dag Torfoss, Elin Velle, Hilde Skuterud Wik, Waleed Ghanima, Per Morten Sandset, Anders EA Dahm
Journal: Blood
Blood (2021) 138 (Supplement 1): 3231.
https://doi.org/10.1182/blood-2021-148105
Published: 2021
Journal Articles

Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment

Brief Report
Olav Erich Yri, Dag Torfoss, Olav Hungnes, Anne Tierens, Kristian Waalen, Tone Nordøy, Susanne Dudman, Anette Kilander, Karin Fahl Wader, Bjørn Østenstad, Roald Ekanger, Peter Meyer, Arne Kolstad
Journal: Blood
Blood (2011) 118 (26): 6769–6771.
https://doi.org/10.1182/blood-2011-08-372649
Published: 2011